These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27730516)

  • 1. Corticomuscular Coherence: a Novel Tool to Assess the Pyramidal Tract Dysfunction in Spinocerebellar Ataxia Type 2.
    Velázquez-Pérez L; Tünnerhoff J; Rodríguez-Labrada R; Torres-Vega R; Belardinelli P; Medrano-Montero J; Peña-Acosta A; Canales-Ochoa N; Vázquez-Mojena Y; González-Zaldivar Y; Auburger G; Ziemann U
    Cerebellum; 2017 Apr; 16(2):602-606. PubMed ID: 27730516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal corticospinal tract function and motor cortex excitability in non-ataxic SCA2 mutation carriers: A TMS study.
    Velázquez-Pérez L; Rodríguez-Labrada R; Torres-Vega R; Medrano Montero J; Vázquez-Mojena Y; Auburger G; Ziemann U
    Clin Neurophysiol; 2016 Aug; 127(8):2713-2719. PubMed ID: 27417041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early corticospinal tract damage in prodromal SCA2 revealed by EEG-EMG and EMG-EMG coherence.
    Velázquez-Pérez L; Tünnerhoff J; Rodríguez-Labrada R; Torres-Vega R; Ruiz-Gonzalez Y; Belardinelli P; Medrano-Montero J; Canales-Ochoa N; González-Zaldivar Y; Vazquez-Mojena Y; Auburger G; Ziemann U
    Clin Neurophysiol; 2017 Dec; 128(12):2493-2502. PubMed ID: 29101844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central motor conduction to lower limb after transcranial magnetic stimulation in spinocerebellar ataxia type 2 (SCA2).
    Restivo DA; Giuffrida S; Rapisarda G; Antonuzzo A; Saponara R; Reggio A; Trovato Salinaro A; Raffaele R; Domina E; Trovato A; Condorelli DF; Pennisi G
    Clin Neurophysiol; 2000 Apr; 111(4):630-5. PubMed ID: 10727914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of corticospinal tract dysfunction in pre-ataxic spinocerebellar ataxia type 2: A two-years follow-up TMS study.
    Velázquez-Pérez L; Rodríguez-Labrada R; Torres-Vega R; Ortega-Sánchez R; Medrano-Montero J; González-Piña R; Vázquez-Mojena Y; Auburger G; Ziemann U
    Clin Neurophysiol; 2018 May; 129(5):895-900. PubMed ID: 29550649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EMG Rectification Is Detrimental for Identifying Abnormalities in Corticomuscular and Intermuscular Coherence in Spinocerebellar Ataxia Type 2.
    Ruiz-Gonzalez Y; Velázquez-Pérez L; Rodríguez-Labrada R; Torres-Vega R; Ziemann U
    Cerebellum; 2020 Oct; 19(5):665-671. PubMed ID: 32500511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged central motor conduction time of lower limb muscle in spinocerebellar ataxia 6.
    Chen JT; Lin YY; Lee YC; Soong BW; Wu ZA; Liao KK
    J Clin Neurosci; 2004 May; 11(4):381-3. PubMed ID: 15080952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pattern of Peripheral Nerve Involvement in Spinocerebellar Ataxia Type 2: a Neurophysiological Assessment.
    Bezerra ML; Pedroso JL; Braga-Neto P; Abrahao A; de Albuquerque MV; Borges FR; Saraiva-Pereira ML; Jardim LB; de Oliveira Braga NI; Manzano GM; Barsottini OG
    Cerebellum; 2016 Dec; 15(6):767-773. PubMed ID: 26708559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central motor conduction time in spinocerebellar ataxia: a meta-analysis.
    Tang ZC; Chen Z; Shi YT; Wan LL; Liu MJ; Hou X; Wang CR; Peng HR; Peng LL; Qiu R; Tang BS; Jiang H
    Aging (Albany NY); 2020 Nov; 12(24):25718-25729. PubMed ID: 33232267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central motor conduction time as prodromal biomarker in spinocerebellar ataxia type 2.
    Velázquez-Pérez L; Rodríguez-Labrada R; Torres-Vega R; Montero JM; Vazquez-Mojena Y; Auburger G; Ziemann U
    Mov Disord; 2016 Apr; 31(4):603-4. PubMed ID: 26880026
    [No Abstract]   [Full Text] [Related]  

  • 11. [Spinocerebellar ataxias type 1 and 2: comparison of clinical, electrophysiological and magnetic resonance evaluation].
    Rakowicz M; Zdzienicka E; Poniatowska R; Waliniowska E; Sułek A; Jakubowska T; Niedzielska K; Rola R; Wierzbicka A; Hoffman-Zacharska D; Głazowski C; Jakubczyk T; Niewiadomska M; Zaremba J
    Neurol Neurochir Pol; 2005; 39(4):263-275. PubMed ID: 16096942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
    Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal cord injury affects I-wave facilitation in human motor cortex.
    Nardone R; Höller Y; Bathke AC; Orioli A; Schwenker K; Frey V; Golaszewski S; Brigo F; Trinka E
    Brain Res Bull; 2015 Jul; 116():93-7. PubMed ID: 26151771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in cortical excitability and central motor conduction time in spinocerebellar ataxias 1, 2 and 3: a comparative study.
    Jhunjhunwala K; Prashanth DK; Netravathi M; Jain S; Purushottam M; Pal PK
    Parkinsonism Relat Disord; 2013 Mar; 19(3):306-11. PubMed ID: 23219306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic scoliosis: a transcranial magnetic stimulation study.
    Kimiskidis VK; Potoupnis M; Papagiannopoulos SK; Dimopoulos G; Kazis DA; Markou K; Zara F; Kapetanos G; Kazis AD
    J Musculoskelet Neuronal Interact; 2007; 7(2):155-60. PubMed ID: 17627085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Only the Fastest Corticospinal Fibers Contribute to β Corticomuscular Coherence.
    Ibáñez J; Del Vecchio A; Rothwell JC; Baker SN; Farina D
    J Neurosci; 2021 Jun; 41(22):4867-4879. PubMed ID: 33893222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
    Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Schöls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; Bürk K; Peltz A; Schulz JB; Dufaure-Garé I; Klockgether T
    Lancet Neurol; 2013 Jul; 12(7):650-8. PubMed ID: 23707147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varied electrophysiologic patterns in spinocerebellar ataxia type 2.
    Crum BA; Josephs KA
    Eur J Neurol; 2006 Feb; 13(2):194-7. PubMed ID: 16490053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-ataxic manifestations of Spinocerebellar ataxia-2, their determinants and predictors.
    Stezin A; Venkatesh SD; Thennarasu K; Purushottam M; Jain S; Yadav R; Pal PK
    J Neurol Sci; 2018 Nov; 394():14-18. PubMed ID: 30196130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological features of central motor conduction in spinocerebellar atrophy type 1, type 2, and Machado-Joseph disease.
    Yokota T; Sasaki H; Iwabuchi K; Shiojiri T; Yoshino A; Otagiri A; Inaba A; Yuasa T
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):530-4. PubMed ID: 9771779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.